Tag: G10 Medicine group

Section Sponsors

NEWS
EU steps up response to Syrian massacre
The United States and at least seven other Western countries expelled Syrian diplomats from their capitals yesterday (29 May) in a coordinated action against President Bashar al-Assad's government over the killing of more than 100 civilians in a Syrian town. An EU-wide expulsion, however, has not been decided.

News | France hesitates on federalist leap to save the euro
News | Russian Ambassador: 'EU is like a crocodile'
News | EU emissions rise despite climate change policies
News | Brussels mulls cross-border rules to wind up failing banks
News | British MPs want food law to better protect consumers
Hot topics
SPECIAL REPORTS
Special Reports
LINKSDOSSIERS

REACH chemical safety review: Re-opening a can of worms?
Five years after its adoption, the European Commission is preparing to review the controversial REACH regulation, which for the first time required chemical manufacturers to justify that their products are safe for consumers before placing them on the market.

LinksDossier | Cutting energy use in Europe's old building stock: Mission impossible?
LinksDossier | Visa-free travel for the EU's East: The next frontier
LinksDossier | Austerity: Healthcare in hardship
LinksDossier | Cloud computing: A legal maze for Europe
LinksDossier | Digital agenda: Connecting the EU
INTERVIEWS

Turunen MEP: 'There are many situations that can make us vulnerable as consumers'
Danish MEP Emilie Turunen explains why the European Commission should strengthen protections for the elderly, disabled and other potentially vulnerable consumers.

Interview | EUrid: Being green pays off in increased competitiveness
Interview | Packaging boss: 'Paper for recycling is short in Europe'
Interview | Foreign Minister: 'Lithuania could adopt the euro after some time'
Interview | Internet guru warns users to play safe
Interview | Industry chief: Pricing, policies should promote water efficiency
OPINIONS

The Egyptian Election and the Arab Spring
Westerners have underestimated the extent of the support for the military regime in Egypt and the degree to which anti-Mubarak demonstrators were committed to Western-style democracy rather than a democracy that represented Islamic values, writes George Friedman.

Opinion | Greece's choice: a hard landing or a crash
Opinion | Energy efficiency: a clear path to a green future
Opinion | Europe Needs a Real Growth Agenda
Opinion | Energy savings: The stimulus Europe needs
Opinion | The water crisis is now
BLOGS

Promoting the EU via the works of Dan Brown?
It’s very interesting from a communication point of view, to analyses the books written by Dan Brown. The impact of ‘The Da Vinci Code’ was hug..

Blog | Wahlsieg François Hollandes
Blog | Tocando fondo, Spain is touching bottom
Blog | Spain: the new ‘sick man of Europe’
Blog | When the EU naively protects individuals from themselves
Blog | Europa muss nach Syrien
VIDEOS

New medicines legislation - 11 February 2005 - LinksDossier

A high level of public health protection and the completion of the internal market were the main objectives of the comprehensive reform of the EU's pharmaceutical legislative framework. The review, which started in July 2001 and ended in March 2004, touched upon contentious issues, such as authorisation procedures, information to patients, regulatory data protection and 'pharmaco-vigilance'.

'Informed patient' debate heats up - 01 July 2004 - News

Communicating faster, higher quality and more reliable information to patients was the focus of a round table debate among health professionals.

Experts agree patients should receive more health-related information - 09 June 2004 - News

Patients' right to more information was a recurring theme at a conference on the pharmaceutical sector hosted by Commissioners Byrne and Liikanen.

Interview news: Companies should be allowed to inform patients accurately, says Tom McKillop - 17 March 2004 - News

While patients have access to information on medicines from a variety of sources, companies in the EU with a legal liability cannot communicate on their products, said Tom McKillop, the CEO of AstraZeneca.

Council supports measures to improve pharma industry's competitiveness - 23 September 2003 - News

The Competitiveness Council adopted its own set of conclusions on reinforcing the competitiveness of the EU-based pharmaceutical industry, on 22 September 2003.

Stimulating biotech innovation is key to competitiveness and public health goals - 15 July 2003 - News

The Italian Presidency hosted a stock-taking conference on the G10 process, on 10-11 July 2003, few days after the Commission's adoption of its response to the G10 Medicines Report.

Commission to benchmark pharma industry's competitiveness - 02 July 2003 - News

The Commission adopted a Communication on 1 July, aiming to find a delicate balance between promoting the EU's pharma industry and controlling social spending.

G10 Medicines Group presents report in public forum - 09 May 2002 - News

On 7 May, the G10 Medicines Group met to formally hand over its report to European Commission President Romano Prodi. On this occasion, the high-level group also presented the report in a public forum in order to discuss the next steps.

G10 Medicines Group makes recommendations to enhance pharmaceutical competitiveness - 01 March 2002 - News

On 26 February 2002, the G10 Medicines Group adopted recommendations to enhance competitiveness in the pharmaceutical industry while sustaining high public health standards.

BROWSE ALL SECTIONS

General Sponsors

Section Sponsors

EurActors & Content Partners

EU Press Releases

Agenda

Théâtre National - Brussels

Maastricht

Tag: G10 Medicine group

Recent BlogActiv posts

Social Media

Advertising

Services

Yellow Pages

EurActiv Jobsite

About EurActiv

Press Office

Fondation EurActiv-Politech

Contact us